Evaluating Scalable Supervised Learning for Synthesize-on-Demand Chemical Libraries.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Read ChemRxiv v1 PDF/record and PMC full article. Supervised screening of synthesize-on-demand library; prospective tests found 31/68 PriA-SSB inhibitors, including 1.3 µM hit. Narrowly an in-vitro target-inhibitor discovery; v1 already contains result, predating journal version.
Technology: Read ChemRxiv v1 PDF/record and PMC full article. Supervised screening of synthesize-on-demand library; prospective tests found 31/68 PriA-SSB inhibitors, including 1.3 µM hit. Narrowly an in-vitro target-inhibitor discovery; v1 already contains result, predating journal version.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Read ChemRxiv v1 PDF/record and PMC full article. Supervised screening of synthesize-on-demand library; prospective tests found 31/68 PriA-SSB inhibitors, including 1.3 µM hit. Narrowly an in-vitro target-inhibitor discovery; v1 already contains result, predating journal version.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://chemrxiv.org/engage/chemrxiv/article-details/616dde0df718df8ad1e3422d
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.